| 15932 | R. Scott Kennedy Awarded the 2008 El-Hibri Peace Education Prize |
| 14587 | Former Dhhs Secretary, Dr. Louis W. Sullivan, Joins Board Of Directors Of Emergent Biosolutions |
| 11511 | Fuad El-Hibri Ernst & Young Entrepreneur of the Year |
| 11069 | Bad News Clouds Two Bio Defense Stocks |
| 9537 | Emergent BioSolutions Hosts Biopreparedness Forum for Members of the NATO Parliamentary Assembly |
| 2089 | Emergent Revises Upward 2010 Financial Forecast |
| 2080 | Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Th |
| 1985 | Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing Facility |
| 1894 | Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine |
| 1779 | Colman McCarthy to Receive 2010 EL-HIBRI Peace Education Prize |
| 1766 | Emergent Biosolutions Announces Dr. Stephen Lockhart Joins Company To Lead Commercial Product Development Subsidiary |
| 1106 | Nominations Being Accepted Now for 2010 El-Hibri Peace Education Prize |
| 972 | EMERGENT BIOSOLUTIONS ANNOUNCES EXPANSION OF BOARD OF DIRECTORS AND APPOINTMENT OF DR. SUE BAILEY TO THE COMPANY’S BOARD OF DIRE |
| 962 | October 9, 2008 - Farr Honors Former Santa Cruz Mayor |
| 931 | Emergent BioSolutions to Acquire Trubion Pharmaceuticals |
| 868 | Emergent BioSolutions Awarded HHS Contract Valued at up to $186.6 Million to Develop rPA Anthrax Vaccine |
| 841 | Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young |
| 818 | The El-Hibri Foundation Launches Website |
| 805 | Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments |
| 787 | Emergent Biosolutions Delivers Over 3 Million Doses Of Biothrax® To U.S. Department Of Health And Human Services For Strategic N |
| 784 | Fuad El-Hibri and The National Health Museum |
| 774 | Emergent BioSolutions Buys Rival Vaccine for $2 Million |
| 772 | New TB Vaccine Candidate Enters Phase IIb Proof-of-Concept Trial in South Africa |
| 761 | Board expands with Election of Fuad El-Hibri |
| 758 | Emergent BioSolutions to Release Third Quarter 2010 Financial Results and Conduct a Conference Call on November 4, 2010 |
| 751 | Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars |
| 737 | Oxford-Emergent Tuberculosis Consortium Signs Commercial License Agreement with Vivalis to Explore Production Of MVA85A TB Vacci |
| 736 | Fuad El-Hibri Official Bio Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding Int |
| 730 | Emergent BioSolutions hands out bonuses |
| 708 | Fuad El-Hibri and the International Biomedical Research Alliance |
| 707 | Emergent BioSolutions reacts to BARDA's Request for Proposal cancellation |
| 693 | Emergent BioSolutions to Participate in June 2010 Investor Conferences |
| 674 | Lebanese CEO Sees Opportunity in Current Crisis |
| 670 | Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians |
| 664 | Emergent Biosolutions Announces Management Changes |
| 657 | Washington Launched Me, But I am Proud to be a Lebanese Dreaming of New Technology - Al Anwar |
| 655 | Emergent BioSolutions Presents Positive Data from Its TRU-016 Program at American Society of Hematology Meeting |
| 650 | Fuad El-Hibri on Twine |
| 646 | Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax |
| 645 | Fuad El-Hibri on Webbiographies |
| 628 | Oxford-Emergent Tuberculosis Consortium Vaccinates Last Infant in Phase IIb Clinical Trial |
| 626 | Emergent Biosolutions Receives Development Contract From Niaid/Barda To Fund Continued Development Of Anthrax Therapeutic |
| 624 | Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals |
| 612 | Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore |
| 605 | Emergent looks to buy Maryland lab |
| 605 | Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland |
| 599 | Maker of anthrax vaccine discusses challenges of marketing overseas |
| 596 | Joe M. Allbaugh, Former Fema Director, Joins Emergent Biosolutions’ Board Of Directors |
| 585 | Emergrnt Biosultions on Answers.com |
| 576 | CEO took roundabout path to Emergent |
| 571 | Delegates from European Parliament Express Support for Rapid Development of New TB Vaccine |
| 547 | Nomination Deadline Approaching for 2010 El-Hibri Peace Education Prize |
| 541 | Emergent BioSolutions Announces That BioThrax (Anthrax Vaccine Adsorbed) Receives Market Authorization in India |
| 536 | Fued El-Hibri Profile on Forbes |
| 534 | EMERGENT BIOSOLUTIONS ANNOUNCES MANAGEMENT CHANGES |
| 522 | Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript |
| 518 | Emergent Biosolutions Acquires Monoclonal Anthrax Product Candidate |
| 514 | Fuad El-Hibri Recognized by Vilcek Foundation |
| 505 | Emergent Biosolutions Expands Presence In Germany |
| 497 | U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES REMAINS COMMITTED TO PROCUREMENT OF BIOTHRAX® UNDER CURRENT CONTRACT |
| 476 | EMERGENT BIOSOLUTIONS ANNOUNCES THE APPOINTMENT OF DENISE LANDRY AS SENIOR VICE PRESIDENT, QUALITY |
| 474 | Jerome M. Hauer Named To Board Of Directors Of Emergent Biosolutions |
| 468 | Emergent BioSolutions to Release Fourth Quarter and Full Year 2010 Financial Results and Conduct a Conference Call on March 10 |
| 467 | Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Finalist |
| 466 | Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference |
| 451 | <a href="http://www.muckety.com/Fuad-El-Hibri/8838.muckety">Fuad El- |
| 448 | Fuad El-Hibri is a Washington-Area Success Story |
| 441 | U.S. Government To Purchase Additional 14.5 Million Doses Of Biothrax® Under New Contract Valued At Up To $404 Million |
| 432 | Ernst & Young’s Entrepreneur of the Year Fuad El-Hibri |
| 432 | Emergent BioSolutions Chairman and CEO Fuad El-Hibri Named Biotech CEO of the Year at the World Vaccine Congress |
| 423 | Emergent BioSolutions Announces Initiation of Phase Ib/II Study of TRU-016 in Combination with Bendamustine for Chronic Lymphocy |
| 420 | Fuad El-Hibri and Healthcare Reform |
| 418 | Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Winner in |
| 414 | Emergent BioSolutions Reports Financial Results for First Quarter 2011 |
| 411 | Emergent Biosolutions El-Hibri |
| 410 | About Fuad El-Hibri on Atlanta Business Chronicle |
| 409 | Emergent BioSolutions Observes World TB Day Launches “OETC: Endeavor to End Tuberculosis,” a video to raise public awareness of |
| 398 | Fuad El-Hibri’s Linkedin Profile |
| 398 | Emergent BioSolutions moves forward with typhoid vaccine |
| 397 | Peace Prize awarded to Center for Nonviolence’s Kennedy |
| 397 | Emergent biosolutions announces that department OF HEALTH AND HUMAN SERVICES AND DEPARTMENT OF DEFENSE ISSUED NOTICES OF INTENT |
| 384 | EMERGENT BIOSOLUTIONS’ TYPHOID VACCINE CANDIDATE ACHIEVES ENDPOINTS IN PHASE II CLINICAL STUDY |
| 377 | Digg Fuad El-Hibri |
| 376 | Fuad El-Hibri on Wikipedia |
| 373 | EMERGENT BIOSOLUTIONS ANTICIPATES 2ND QUARTER BIOTHRAX REVENUES OF APPROXIMATELY $20 MILLION BASED ON ACCELERATED DELIVERY TO DE |
| 356 | Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference |
| 352 | EMERGENT BIOSOLUTIONS INC Profile on AOL |
| 352 | Rene Moawad Foundation (RMF) USA Holds 14th Annual Washington Gala Dinner |
| 351 | Fuad El-Hibri on Businessweek |
| 348 | EMERGENT BIOSOLUTIONS SIGNS $448 MILLION THREE YEAR CONTRACT WITH DEPARTMENT OF HEALTH AND HUMAN SERVICES |
| 345 | Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule |
| 344 | Emergent BioSolutions Reports Financial Results for Full Year 2010 |
| 342 | Fuad El-Hibri on Corridor Inc. |
| 338 | Emergent BioSolutions Chairman and CEO Fuad El-Hibri Appointed to U.S. Chamber of Commerce Board of Directors |
| 323 | Emergent BioSolutions and Ninebio Sdn. Bhd. AnnounceJoint Venture in Malaysia. |
| 319 | Emergent BioSolutions To Acquire Protein Sciences’ Phase III Recombinant Flu Vaccine Candidate, FluBlok(R), And Related Novel Pl |
| 318 | EMERGENT BIOSOLUTIONS ANNOUNCES RESULTS FROM ANNUAL MEETING OF STOCKHOLDERS |
| 317 | Emergent BioSolutions Inc. (EBS) CEO & Chairman, 10% Owner Fuad El-hibri sells 15,000 Shares |
| 314 | Fuad El-Hibri on Social Networks |
| 309 | Fuad El-Hibri Profiles |
| 308 | Fuad El-Hibri El-Hibri Peace Education Prize |
| 296 | Emergent Announces Initiation of a Phase 1b/2 Study of TRU-016 in Combination with Rituximab and Bendamustine |
| 274 | STATEMENT BY FUAD EL-HIBRI, EMERGENT BIOSOLUTIONS CHAIRMAN AND CHIEF EXECUTIVE OFFICER, ON THE PASSING OF ADMIRAL WILLIAM CROWE, |
| 264 | Fuad El-Hibri Earnings Call |
| 253 | Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax |
| 250 | Emergent BioSolutions' Investigational Anthrax Vaccine, NuThrax, Granted Fast Track Designation |
| 224 | Fuad El-Hibri and the Heifetz International Music Institute |
| 213 | Emergent BioSolutions to Present at Wedbush 2011 Life Sciences Conference |
| 165 | Fuad El-Hibri Interviewed by Ricardo Karam |
| 143 | Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference in London |
| 130 | FUAD EL-HIBRI TO AWARD 2011 EL-HIBRI PEACE EDUCATION PRIZE TO GENE SHARP |
| 127 | Fuad El-Hibri on Arabian Business Power 500 |
| 91 | Fuad El-Hibri and the TAKREEM Achievement Awards |
| 84 | Fuad El-Hibri Announces Emergent BioSolutionsAward to Supply BioThrax Anthrax Vaccine to U.S. Government |
| 5 | Emergent BioSolutions to Release Fourth Quarter and Full Year 2011 Financial Results and Conduct a Conference Call on March 8, 2 |
